Anitta Ahonen

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

Timo Vesikari, Joanne M. Langley, Nathan Segall et al. · The Lancet Infectious Diseases · 2021 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

Timo Vesikari, Adam Finn, Pierre Van Damme et al. · JAMA Network Open · 2021 · 61 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study

Elmar A. Joura, Àngels Ulied, Corinne Vandermeulen et al. · Vaccine · 2021 · 39 citations

Medicine, Immunology, Immunization +11

Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study

Stéphanie Pépin, Henryk Szymański, Ilya Angélica Rochín Kobashi et al. · Human Vaccines & Immunotherapeutics · 2016 · 26 citations · Full text

Veterinary Medicine, Child Health, Immunology +17

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

Nicola P. Klein, Remon Abu‐Elyazeed, Michael Povey et al. · Journal of the Pediatric Infectious Diseases Society · 2019 · 19 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17